QA: Regulus Therapeutics Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001505512_2017_Regulus_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001505512, Regulus Therapeutics Inc

  xvar xval
0 AssetsCurrent 87,474,000
1 IntangibleAssetsNetIncludingGoodwill 1,015,000
2 PropertyPlantAndEquipmentNet 11,830,000
3 remainder_Assets 342,000
4 LiabilitiesCurrent 13,807,000
5 LiabilitiesNoncurrent 144,000
6 remainder_Liabilities 30,635,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,779,494
9 ResearchAndDevelopmentExpense 79,008,510
10 remainder_Expenses 701,801
11 remainder_Revenues 13,071,299
12 remainder_NetIncome -698,509
13 remainder_ComprehensiveNetIncome 33,963
  yvar yval
0 Assets 100,661,000
1 Liabilities 44,586,000
2 Expenses 97,489,805
3 Revenues 13,071,299
4 StockholdersEquity 56,075,000
5 NetIncome -85,117,015
6 ComprehensiveNetIncome -85,100,034
7 BaseVar 128,270,288
8 EconomicCapitalRatiobeforeLimitedLiability 0.511
9 EconomicCapitalRatio 1.89

Edgar->Model Mapping

Feature Distribution

Change over Time